In addition, after evaluating the likelihood of survival for various HCC patients, it was discovered that individuals with elevated levels of RALY had a decreased overall survival compared to those with lower levels of RALY (Figure 1C). This evidence concerns the gene RALY and hepatocellular carcinoma.